These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6152328)

  • 41. Hypothermia elicited by some prodynorphin-derived peptides: opioid and non-opioid actions.
    Cavicchini E; Candeletti S; Spampinato S; Ferri S
    Neuropeptides; 1989 Jul; 14(1):45-50. PubMed ID: 2571107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of intranigral injections of dynorphin, dynorphin fragments and alpha-neoendorphin on rotational behaviour in the rat.
    Herrera-Marschitz M; Hökfelt T; Ungerstedt U; Terenius L; Goldstein M
    Eur J Pharmacol; 1984 Jul; 102(2):213-27. PubMed ID: 6148248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dynorphins and Leu-enkephalin in brain nuclei and pituitary of WKY and SHR rats.
    Feuerstein G; Molineaux CJ; Rosenberger JG; Faden AI; Cox BM
    Peptides; 1983; 4(2):225-9. PubMed ID: 6622288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Centrally mediated cardiovascular actions of dynorphin A(1-8) on rat hippocampal formation.
    Wang JQ; Ingenito AJ
    J Pharmacol Exp Ther; 1992 May; 261(2):678-85. PubMed ID: 1349645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Some projections of dynorphin-immunoreactive neurons in the rat central nervous system.
    Code RA; Fallon JH
    Neuropeptides; 1986; 8(2):165-72. PubMed ID: 2429230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat.
    Shippenberg TS; Funada M; Schutz CG
    Psychopharmacology (Berl); 2000 Sep; 151(4):351-8. PubMed ID: 11026742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Des-Tyr1]dynorphin A-(2-17) has naloxone-insensitive antinociceptive effect in the writhing assay.
    Hooke LP; He L; Lee NM
    J Pharmacol Exp Ther; 1995 May; 273(2):802-7. PubMed ID: 7752083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opioidergic projections to sleep-active neurons in the ventrolateral preoptic nucleus.
    Greco MA; Fuller PM; Jhou TC; Martin-Schild S; Zadina JE; Hu Z; Shiromani P; Lu J
    Brain Res; 2008 Dec; 1245():96-107. PubMed ID: 18840417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Central and systemic kappa-opioid agonists exacerbate neurobehavioral response to brain injury in rats.
    McIntosh TK; Fernyak S; Yamakami I; Faden AI
    Am J Physiol; 1994 Sep; 267(3 Pt 2):R665-72. PubMed ID: 7916537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A dynorphin peptide induces hypotension by stimulating the release of atrial natriuretic peptide from rat atrium.
    Xie CW; Yin LY; Xie XZ; Gao XM; Xia ZQ; Chang JK; Tang J
    Life Sci; 1988; 42(11):1117-22. PubMed ID: 2894603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice.
    Takemori AE; Loh HH; Lee NM
    J Pharmacol Exp Ther; 1993 Jul; 266(1):121-4. PubMed ID: 8101214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endogenous dynorphin modulates calcium-mediated antinociception in mice.
    Smith FL; Dewey WL
    Pharmacol Biochem Behav; 1993 Jun; 45(2):383-91. PubMed ID: 8101006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self-administration of dynorphin-[1-13] and D-ala2-dynorphin-[1-11] (kappa opioid agonists) in morphine (mu opioid agonist)-dependent rats.
    Khazan N; Young GA; Calligaro D
    Life Sci; 1983; 33 Suppl 1():559-62. PubMed ID: 6319910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects on Hedonic Feeding, Energy Expenditure and Balance of the Non-opioid Peptide DYN-A
    Alvarez B; Barrientos T; Gac L; Teske JA; Perez-Leighton CE
    Neuroscience; 2018 Feb; 371():337-345. PubMed ID: 29203229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of dynorphin microinjection in the anterior hypothalamus (AV3V) region on the hemodynamic response to hemorrhage in the rat.
    Fan L; Yeston NS; McIntosh TK
    Circ Shock; 1993 Feb; 39(2):147-52. PubMed ID: 8098273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures.
    Kong LY; McMillian MK; Hudson PM; Jin L; Hong JS
    J Pharmacol Exp Ther; 1997 Jan; 280(1):61-6. PubMed ID: 8996182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular responses to intra-hippocampal dynorphin A-(1-8) in spontaneously hypertensive rats.
    Wang JQ; Ingenito AJ
    Eur J Pharmacol; 1994 Apr; 256(1):57-64. PubMed ID: 7913047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of the ventromedial hypothalamus in the regulation of adenohypophyseal immunoreactive dynorphin in the rat.
    Spampinato S; Stanzani S; Leanza G; Russo A; Ferri S
    Brain Res; 1988 Oct; 463(1):100-6. PubMed ID: 2904293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular effects of microinjection of dynorphin fragments into the nucleus of the solitary tract (NTS) are mediated by non-opioid mechanisms.
    Fan L; McIntosh TK
    Brain Res; 1993 Sep; 623(1):110-6. PubMed ID: 8106118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.